Skřičková, J, Bortlíček, Z, Hejduk, K, Pešek, M, Zatloukal, P, Kolek, V, Salajka, F, Koubková, L, Čoupková, H, Zemanová, M. The Czech Republic experience with erlotinib in the treatment of a non-selected non-small cell lung cancer (NSCLC) population of 2365 patients (pts).
Skřičková, J, Bortlíček, Z, Hejduk, K, Pešek, M, Zatloukal, P, Kolek, V, Salajka, F, Koubková, L, Čoupková, H, Zemanová, M. The Czech Republic experience with erlotinib in the treatment of a non-selected non-small cell lung cancer (NSCLC) population of 2365 patients (pts).